Intellectual Property India Publishes Patent Application for 'Substituted Imidazo [1, 2-A] Pyridine Compounds And The Use Thereof In The Treatment And Prevention Of Fibrosis' Filed by Moexa Pharmaceuticals Limited

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202517013549 A) filed by Moexa Pharmaceuticals Limited, Hong Kong, on Feb. 17, for 'substituted imidazo [1, 2-a] pyridine compounds and the use thereof in the treatment and prevention of fibrosis.'

Inventor(s) include Lo, Ho Yin; and Porter, Robert Stephen.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "Provied are a class of substituted imidazo[1,2-a]pyridine compounds, pharmaceutical compositions containing the same, and use of the compounds in the treatment and prevention of fibrosis."

The patent application was internationally filed on Jul...